Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery

CMAJ. Canadian Medical Association Journal

Volumn 160, Issue 7, 1999, Pages 997-1002

  Dupuis, Jean Yves ^a   Bart, Bevin ^a   Bryson, Gregory ^a   Robblee, James ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ADULT; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION; COMPARATIVE STUDY; COMPLICATION; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK; STATISTICS;

EID: 0033528677     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Love TR, Hendren WG, O'Keefe DD, Daggert WM. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 1987; 43:508-12.
2. Owings DV, Krustall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 1989;262:1963-8.
3. Britton LW, Eastlund DT, Dziuban SW, Foster ED, McIlduff JB, Canavan TE, et al. Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg 1989;47:529-32.
4. Dzik WH, Fleisher AG, Ciavarella D, Karlson KJ, Reed GE, Berger RL. Safety and efficacy of autologous blood donation before elective aortic valve operation. Ann Thorac Surg 1992;54:1177-81.
5. Sandrelli L, Pardini A, Lorusso R, Sala ML, Licenziati M, Alfieri O. Impact of autologous blood predonation on a comprehensive blood conservation program. Ann Thorac Surg 1995;59:730-5.
6. Wasman J, Goodnough T. Autologous blood donation for elective surgery. Effect on physician transfusion behavior. JAMA 1987;258:3135-7.
7. Forgie M, Wells P, Laupacis A, Fergusson D, for the International Study of Perioperative Transfusion (ISPOT) Investigators. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion. Arch Intern Med 1998;158:610-6.
8. Richards C, Kolins J, Trindale CD. Autologous transfusion-transmitted Yersinia enterolitica [letter]. JAMA 1992;268:1541-2.
9. Linden JV, Kaplan HS. Transfusion errors: causes and effects. Transfus Med Rev 1994;8:169-83.
10. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992;32:601-6.
11. Goldman M, Remy-Prince S, Trepanier A, Decary F. Autologous donation error rates in Canada. Transfusion 1997;37:523-7.
12. Gould SA, Forbes JM. Controversies in transfusion medicine - indications for autologous and allogeneic transfusion should be the same: pro. Transfusion 1995;35:446-9.
13. Miller RD, von Ehrenburg W. Controversies in transfusion medicine - indications for autologous and allogeneic transfusion should be the same: con. Transfusion 1995;35:450-2.
14. Coffin C, Matz K, Rich E. Algorithms for evaluating the appropriateness of blood transfusion. Transfusion 1989;29:298-303.
15. Stehling L, Luban NLC, Anderson KC, Sayers MH, Long A, Attar S, Leitman SF, Gould SA, Kruskall MS, Goodnough LT, Hines DM. Guidelines for blood utilization review. Transfusion 1994;34:438-48.
16. Magovern JA, Sakert T, Benckart DH, Burkholder JA, Liebler GA, Magovern GJ Sr, et al. A model for predicting transfusion after coronary artery bypass. Ann Thorac Surg 1996;61:27-32.
17. Surgenor DM, Churchill WH, Wallace EL, Rizzo RJ, Chapman RH, McGurk S, et al. Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study. Transfusion 1996;36:521-32.
18. Tuman KJ, McCarthy RJ, March RJ, Hassan N, Ivankovich AD. Morbidity and duration of ICU stay after cardiac surgery. A model for preoperative risk assessment. Chest 1992;102:36-44.
19. Calder L, Hébert PC, Carter AO, Graham ID. Review of published recommendations and guidelines for the transfusion of allogeneic red blood cells and plasma. CMAJ 1997;156(11 Suppl):S1-S8.
20. Magovern JA, Sakert T, Magovern GJ, Benckart DH, Burkholder JA, Liebler GA, et al. A model that predicts morbidity and mortality after coronary artery bypass graft surgery. J Am Coll Cardiol 1996;28:1147-53.
21. Laupacis A. Alternatives to blood transfusion are risky too [letter]. CMAJ 1998;159:137.
22. Goodnough LT, Monk TG. Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infarction. Am J Med 1996;101(Suppl 2A):33S-37S.
23. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995;35:734-7.
24. Birkmeyer JD, AuBuchon JP, Littenberg B, O'Connor GT, Nease RF, Nugent WC, et al. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 1994;57:161-9.
25. AuBuchon JP. Cost-effectiveness of preoperative autologous blood donation for orthopedic and cardiac surgeries. Am J Med 1996;101(Suppl 2A):38S-42S.
26. Commission of Inquiry on the Blood System in Canada. Final report. Ottawa: Canadian Government Publishing - PWGSC; 1997. p. 1046-73.